Multicenter cohort study of out-of-hospital pediatric cardiac arrest

Pediatric Emergency Care Applied Research Network, Salt Lake City, UT, USA.
Critical care medicine (Impact Factor: 6.31). 10/2010; 39(1):141-9. DOI: 10.1097/CCM.0b013e3181fa3c17
Source: PubMed


To describe a large cohort of children with out-of-hospital cardiac arrest with return of circulation and to identify factors in the early postarrest period associated with survival. These objectives were for planning an interventional trial of therapeutic hypothermia after pediatric cardiac arrest.
A retrospective cohort study was conducted at 15 Pediatric Emergency Care Applied Research Network clinical sites over an 18-month study period. All children from 1 day (24 hrs) to 18 yrs of age with out-of-hospital cardiac arrest and a history of at least 1 min of chest compressions with return of circulation for at least 20 mins were eligible.
One hundred thirty-eight cases met study entry criteria; the overall mortality was 62% (85 of 138 cases). The event characteristics associated with increased survival were as follows: weekend arrests, cardiopulmonary resuscitation not ongoing at hospital arrival, arrest rhythm not asystole, no atropine or NaHCO3, fewer epinephrine doses, shorter duration of cardiopulmonary resuscitation, and drowning or asphyxial arrest event. For the 0- to 12-hr postarrest return-of-circulation period, absence of any vasopressor or inotropic agent (dopamine, epinephrine) use, higher lowest temperature recorded, greater lowest pH, lower lactate, lower maximum glucose, and normal pupillary responses were all associated with survival. A multivariate logistic model of variables available at the time of arrest, which controlled for gender, age, race, and asystole or ventricular fibrillation/ventricular tachycardia anytime during the arrest, found the administration of atropine and epinephrine to be associated with mortality. A second model using additional information available up to 12 hrs after return of circulation found 1) preexisting lung or airway disease; 2) an etiology of arrest drowning or asphyxia; 3) higher pH, and 4) bilateral reactive pupils to be associated with lower mortality. Receiving more than three doses of epinephrine was associated with poor outcome in 96% (44 of 46) of cases.
Multiple factors were identified as associated with survival after out-of-hospital pediatric cardiac arrest with the return of circulation. Additional information available within a few hours after the return of circulation may diminish outcome associations of factors available at earlier times in regression models. These factors should be considered in the design of future interventional trials aimed to improve outcome after pediatric cardiac arrest.

Download full-text


Available from: Kelly S Tieves,
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Relay is used in LTE-Advanced cellular networks to assist eNB(evolved Node Base-station) for coverage extension and throughput enhancement. Compared to eNB, relay is advantageous on both equipment cost and site cost. How to deploy relays to maximize the performance gain with a reasonable cost subject to a number of system constraints such as interference caused and backhaul subframe allocation is an important yet challenging issue. In this paper, we provide a solution for cost-efficient deployment of relays in LTE-A cellular networks. We establish a mathematical model to analyze the tradeoff between the deployment cost and the cell performance gain, and the tradeoff between overall cell performance and satisfaction level for individual users. Our interesting findings in this paper include: (1) the best cost-efficient number of relays in a cell is limited to a reasonable range between 7 and 11 for static relay deployment; (2) when progressive deployment is considered, the optimal number of relays decreases to 4 to achieve tradeoff gain between overall cell capacity and average user satisfaction level.
    Proceedings of IEEE International Conference on Communications, ICC 2011, Kyoto, Japan, 5-9 June, 2011; 01/2011

  • Critical care medicine 01/2011; 39(1):218-9. DOI:10.1097/CCM.0b013e3181ffe254 · 6.31 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Brain injury is the leading cause of death in pediatric intensive care units, and improvements in therapy and in understanding the pathogenesis are urgently needed. This review presents recent advances in the understanding of neuroprotective therapy and brain-specific monitoring for critically ill pediatric patients. Two neuroprotective strategies are becoming increasingly accepted as they are applied to different mechanisms of brain injury. The rapid application of hypothermia and avoidance of hyperoxia after cardiac arrest and other brain injuries are each being more commonly used as both human and animal data advocating for these approaches accumulate. In addition, more advanced and noninvasive technologies are emerging that are designed to serve as surrogates for brain function and may be used to help predict outcome. Near-infrared spectroscopy is one such commonly used technique that has prompted many studies to understand how to incorporate it into practice. Protection of the pediatric brain from both a primary insult and the common subsequent secondary injury is essential for improving long-term neurologic outcomes. Whereas monitoring technology is being constantly modified, it must be proven efficacious in order to understand the utility of new and presumed neuroprotective therapies like hypothermia and avoidance of hyperoxia.
    Current opinion in pediatrics 04/2011; 23(3):275-80. DOI:10.1097/MOP.0b013e3283460584 · 2.53 Impact Factor
Show more